Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure

BACKGROUND: The safety of once-daily (qd) dosing of valsartan in heart failure (HF) patients is not known. HYPOTHESIS: This 10-week, double-blind trial examined the relative safety and efficacy of valsartan administered qd versus twice-daily (bid). METHODS: HF patients (NYHA class II–III) receiving...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Anand, Inder S, Deswal, Anita, Kereiakes, Dean J, Purkayastha, Das, Zappe, Dion H
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922305/
https://ncbi.nlm.nih.gov/pubmed/20730060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados